Orion Biotech Opportunities (Orion Biotech Opportunities) EV-to-Revenue : (As of Jun. 10, 2024)

Orion Biotech Opportunities EV-to-Revenue Chart

Competitive Comparison of Orion Biotech Opportunities's EV-to-Revenue

For the Shell Companies subindustry, Orion Biotech Opportunities's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Biotech Opportunities's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Orion Biotech Opportunities's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Orion Biotech Opportunities's EV-to-Revenue falls into.

Orion Biotech Opportunities EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Orion Biotech Opportunities's EV-to-Revenue for today is calculated as:

Orion Biotech Opportunities's current Enterprise Value is $0.00 Mil.
Orion Biotech Opportunities's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Biotech Opportunities  (OTCPK:ORIAU) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Orion Biotech Opportunities's PS Ratiofor today is calculated as:

Orion Biotech Opportunities's share price for today is $9.00.
Orion Biotech Opportunities's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Biotech Opportunities EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Biotech Opportunities (Orion Biotech Opportunities) Business Description